Brain circuits are known to gradually form and develop after birth as the result of both innate biological processes and life ...

A baby diagnosed with spinal muscular atrophy (SMA) was successfully treated in the womb for the first time. Now over two ...

The mother took the drug daily for six weeks while the baby herself was given the drug orally, roughly one week after the ...

An infant with a fatal genetic disease has survived past the age of 2 with no signs of the condition, thanks to treatment ...

Spinal muscular atrophy (SMA) is a debilitating genetic condition that’s usually fatal by a few years of age. But an ...

Rett syndrome is a rare genetic disease affecting 1 in 10,000 newborn girls, characterized by sudden regression around 1 year ...

Looking for the perfect gift for a newborn? Our guide to the best newborn gift packs features premium, eco-friendly, and ...

Scientists report results from a promising new approach to treat the rare neurodegenerative disorder. Spinal muscular atrophy (SMA) is a progressive neurodegenerative disorder set in motion before ...

A new study will investigate whether prenatal antibiotic use impairs breast milk immune function and disrupts neonatal gut ...

Researchers at the Josep Carreras Leukaemia Research Institute revealed a new aspect of Rett Syndrome’s pathogenesis that can ...

The first prenatal therapy for spinal muscular atrophy (SMA) showed promising results, a case report indicated. More than 2 ...

Evrysdi, marketed by Genentech, a Roche company, is a disease-modifying therapy designed to target the genetic root cause of SMA by increasing the production of the missing functional survival motor ...